Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
出版年份 2020 全文链接
标题
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-01-21
DOI
10.3389/fmicb.2019.03116
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers
- (2019) Arshia Ghanbari et al. Scientific Reports
- Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer
- (2019) Rashmi Deshpande et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Epidemiology and burden of HPV-related disease
- (2018) Beatriz Serrano et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Synthetic siRNA targeting human papillomavirus 16 E6: a perspective on in vitro nanotherapeutic approaches
- (2018) Melissa Togtema et al. Nanomedicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
- (2018) Sumitra Shankar et al. Cancer Cell International
- CRISPR/Cas9‑mediated cervical cancer treatment targeting human papillomavirus E6
- (2018) Takahiro Yoshiba et al. Oncology Letters
- The low-risk papillomaviruses
- (2017) Nagayasu Egawa et al. VIRUS RESEARCH
- Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation
- (2017) Yiyu Zhang et al. Oncotarget
- TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells
- (2017) Sumitra Shankar et al. Scientific Reports
- Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
- (2016) Addison V. Wright et al. CELL
- Current state in the development of candidate therapeutic HPV vaccines
- (2016) Andrew Yang et al. Expert Review of Vaccines
- Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells
- (2016) Sae-Bom Kwon et al. PLoS One
- Myc and cell cycle control
- (2015) Gabriel Bretones et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer
- (2015) Radha Munagala et al. CANCER LETTERS
- Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
- (2015) L. M. Draper et al. CLINICAL CANCER RESEARCH
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Human papillomavirus molecular biology and disease association
- (2015) John Doorbar et al. REVIEWS IN MEDICAL VIROLOGY
- Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
- (2014) N Wang et al. BRITISH JOURNAL OF CANCER
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells
- (2014) W. Ding et al. CLINICAL CANCER RESEARCH
- TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
- (2014) Zheng Hu et al. JOURNAL OF CLINICAL INVESTIGATION
- Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
- (2014) E. M. Kennedy et al. JOURNAL OF VIROLOGY
- Expression of Suppressor of Cytokine Signaling 1 (SOCS1) Impairs Viral Clearance and Exacerbates Lung Injury during Influenza Infection
- (2014) Keer Sun et al. PLoS Pathogens
- p53 Family and Cellular Stress Responses in Cancer
- (2014) Johanna Pflaum et al. Frontiers in Oncology
- Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells
- (2013) Man Sub Kim et al. CELL BIOLOGY AND TOXICOLOGY
- Immune alterations and immunotherapy prospects in head and neck cancer
- (2013) Vincent Varilla et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells
- (2013) Xiying Qu et al. NUCLEIC ACIDS RESEARCH
- Gene- and Protein-Delivered Zinc Finger–Staphylococcal Nuclease Hybrid for Inhibition of DNA Replication of Human Papillomavirus
- (2013) Takashi Mino et al. PLoS One
- Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 Function
- (2013) Jonathan J. Cherry et al. PLoS One
- Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines
- (2013) M. E. McLaughlin-Drubin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- The HPV16 E6 Oncoprotein Causes Prolonged Receptor Protein Tyrosine Kinase Signaling and Enhances Internalization of Phosphorylated Receptor Species
- (2013) Jennifer M. Spangle et al. PLoS Pathogens
- Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53
- (2012) A Reschner et al. GENE THERAPY
- Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity
- (2012) E. A. White et al. JOURNAL OF VIROLOGY
- Comparative analysis of virus–host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase
- (2012) Grégory Neveu et al. METHODS
- Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
- (2012) Zarina J. D'Costa et al. PLoS One
- Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses
- (2012) E. A. White et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- Solution Structure Analysis of the HPV16 E6 Oncoprotein Reveals a Self-Association Mechanism Required for E6-Mediated Degradation of p53
- (2012) Katia Zanier et al. STRUCTURE
- Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy
- (2012) Chung-Hsiang Yuan et al. Viruses-Basel
- Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells
- (2011) R. Munagala et al. CARCINOGENESIS
- Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells
- (2011) N. Nor Rashid et al. JOURNAL OF GENERAL VIROLOGY
- Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells
- (2011) Sutapa Mahata et al. Molecular Cancer
- Papillomavirus E5: the smallest oncoprotein with many functions
- (2011) Aldo Venuti et al. Molecular Cancer
- The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis
- (2010) J. M. Spangle et al. JOURNAL OF VIROLOGY
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- Nordihydroguaiaretic acid inhibits growth of cervical cancer SiHa cells by up-regulating p21
- (2010) PENG GAO et al. Oncology Letters
- Expression of a viral oncoprotein in normal human epithelial cells triggers an autophagy-related process: Is autophagy an “Achilles’ heel” of human cancers?
- (2009) Xiaobo Zhou et al. Autophagy
- Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene
- (2009) S. F. Jabbar et al. CANCER RESEARCH
- Efficient double-stranded DNA cleavage by artificial zinc-finger nucleases composed of one zinc-finger protein and a single-chain FokI dimer
- (2009) Takashi Mino et al. JOURNAL OF BIOTECHNOLOGY
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- HPV E6 protein interacts physically and functionally with the cellular telomerase complex
- (2009) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation
- (2009) Xiaobo Zhou et al. VIROLOGY
- HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition
- (2009) Karin Hellner et al. VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now